Flatiron Health, Inc. Overview
Pro stress-test →Flatiron Health is a healthcare technology company that aims to improve lives by learning from the experience of every cancer patient. The company's OncologyCloud platform includes the electronic medical record for oncology, an analytics section for business clinical intelligence, a patient portal, and integrated billing management which allows cancer care providers and life sciences companies to track metrics related to cancer care, match patients to clinical trials and automate data collection.
Strategic Profile
Pro stress-test →Flatiron was acquired by Roche (April 2018), positioning it as a core oncology data and software asset within one of the world's largest pharmaceutical companies. In December 2025, ARCH Ventures-backed Paradigm Health acquired Roche-owned Flatiron Health's clinical research business, while the two companies entered a multi-year partnership to cross-integrate their platforms, aiming to expand access to clinical trials.
Competitive Landscape
Pro stress-test →Flatiron competes in the oncology EMR and healthcare data management segment against specialized players like iQ HealthTech, Electronic Registry Systems, and MedBlob. Its competitive moat stems from Roche's backing, comprehensive platform breadth (EMR + analytics + billing + trial matching), and established network effects across cancer care providers. Most competitors are smaller, specialized point solutions.
Industry Context
Flatiron Health, Inc. operates in Healthcare IT / Oncology Software / Medical Records Systems.
Key facts
Founded: 2012 · Headquarters: New York, US · Employees: 2,500